20122020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Danilo Galizia is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Metastatic disease in head & neck oncology

Pisani, P., Airoldi, M., Allais, A., Aluffi Valletti, P., Battista, M., Benazzo, M., Briatore, R., Cacciola, S., Cocuzza, S., Colombo, A., Conti, B., Costanzo, A., Della Vecchia, L., Denaro, N., Fantozzi, C., Galizia, D., Garzaro, M., Genta, I., Iasi, G. A., Krengli, M. & 17 others, Landolfo, V., Lanza, G. V., Magnano, M., Mancuso, M., Maroldi, R., Masini, L., Merlano, M. C., Piemonte, M., Pisani, S., Prina-Mello, A., Prioglio, L., Rugiu, M. G., Scasso, F., Serra, A., Valente, G., Zannetti, M. & Zigliani, A., Apr 1 2020, In : Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale. 40, p. S1-S86

Research output: Contribution to journalArticle

Open Access

What is the best pharmacotherapeutic strategy for HER-2 positive breast cancer?

Giannone, G., Milani, A., Geuna, E., Galizia, D., Biello, F. & Montemurro, F., Jan 2 2019, In : Expert Opinion on Pharmacotherapy. 20, 1, p. 5-9 5 p.

Research output: Contribution to journalEditorial

Activation of immune responses in patients with relapsed-metastatic head and neck cancer (CONFRONT phase I-II trial): Multimodality immunotherapy with avelumab, short-course radiotherapy, and cyclophosphamide

Merlano, M. C., Merlotti, A. M., Licitra, L., Denaro, N., Fea, E., Galizia, D., Di Maio, M., Fruttero, C., Curcio, P., Vecchio, S., Russi, E. G. & Corvò, R., Aug 2018, In : Clinical and Translational Radiation Oncology. 12, p. 47-52 6 p.

Research output: Contribution to journalArticle

  • Cardiovascular safety of abiraterone acetate in metastatic castration-resistant prostate cancer patients: A prospective evaluation

    Prati, V., Ruatta, F., Aversa, C., Gernone, A., Galizia, D., Bonzano, A., Torino, S., Nuzzolese, I., Marandino, L., Aglietta, M. & Ortega, C., Feb 1 2018, In : Future Oncology. 14, 5, p. 443-448 6 p.

    Research output: Contribution to journalArticle

  • Self-evaluation of duration of adjuvant chemotherapy side effects in breast cancer patients: A prospective study

    Galizia, D., Milani, A., Geuna, E., Martinello, R., Cagnazzo, C., Foresto, M., Longo, V., Berchialla, P., Solinas, G., Calori, A., Grasso, B., Volpone, C., Bertola, G., Parola, G., Tealdi, G., Giuliano, P. L., Ballari, A. M., Aglietta, M. & Montemurro, F., Sep 1 2018, In : Cancer Medicine. 7, 9, p. 4339-4344 6 p.

    Research output: Contribution to journalArticle